Pediatric inflammatory leukoencephalopathies

Omar Abdel-Mannan1, Yael Hacohen1

  • 1Department of Neuroinflammation, Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom; Department of Neurology, Great Ormond Street Hospital, London, United Kingdom.

PubMed

Insights

Acquired demyelinating syndromes (ADS) in children, including multiple sclerosis (MS), are distinct from myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and aquaporin 4-antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD). Differentiating these conditions is crucial for effective treatment strategies.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Demyelinating Diseases

Background:

  • Acquired demyelinating syndromes (ADS) are acute neurological conditions affecting the optic nerve, brain, or spinal cord in children.
  • While multiple sclerosis (MS) is a common relapsing form of ADS, other distinct entities like myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and aquaporin 4-antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) have been identified.
  • Historically considered variants of MS, MOGAD and AQP4-NMOSD are now recognized as separate conditions based on cumulative evidence.

Purpose of the Study:

  • To delineate distinct subtypes of acquired demyelinating syndromes (ADS) in pediatric patients.
  • To highlight the differences between multiple sclerosis (MS), MOGAD, and AQP4-NMOSD despite clinical overlaps.
  • To emphasize the importance of accurate diagnosis for guiding treatment in pediatric ADS.

Main Methods:

  • Review of clinical, biologic, and pathologic evidence differentiating MS, MOGAD, and AQP4-NMOSD.
  • Analysis of diagnostic criteria and phenotypic characteristics of pediatric ADS.
  • Examination of current and emerging therapeutic approaches for these distinct conditions.

Main Results:

  • Biologic, clinical, and pathologic data confirm MOGAD and AQP4-NMOSD as distinct entities from MS.
  • Phenotypic overlaps exist but do not preclude differentiation between MS, MOGAD, and AQP4-NMOSD.
  • Numerous inflammatory and non-inflammatory conditions can mimic ADS in children, necessitating careful diagnosis.

Conclusions:

  • Accurate discrimination between pediatric MS, MOGAD, and AQP4-NMOSD is essential for appropriate patient management.
  • Advances in disease-modifying therapies for MS and emerging treatments for MOGAD and AQP4-NMOSD underscore the need for precise diagnosis.
  • Recognizing mimics of ADS is critical for effective treatment planning in pediatric neurological care.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...